{"product_id":"2022-hfsa-ahftc-board-review","title":"2022 HFSA AHFTC Board Review","description":"\u003cdiv class=\"celwidget\" data-cel-widget=\"bookDescription_feature_div\" data-csa-c-asin=\"\" data-csa-c-content-id=\"bookDescription\" data-csa-c-id=\"sp3pi4-mkskqy-y4o8kl-7jkh2a\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-slot-id=\"bookDescription_feature_div\" data-csa-c-type=\"widget\" data-feature-name=\"bookDescription\" id=\"bookDescription_feature_div\"\u003e\n\u003cdiv class=\"a-expander-collapsed-height a-row a-expander-container a-spacing-base a-expander-partial-collapse-container\" data-a-expander-collapsed-height=\"140\" data-a-expander-name=\"book_description_expander\"\u003e\n\u003cdiv aria-expanded=\"false\" class=\"a-expander-content a-expander-partial-collapse-content\"\u003e\n\u003cdiv class=\"toc-header bottomShadow topPadding\" id=\"toc-header\"\u003e\n\u003cdiv class=\"mura-body\"\u003e\n\u003cdiv class=\"mura-region mura-region-loose\"\u003e\n\u003cdiv class=\"mura-region-local\"\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv class=\"panel entry-content active\" id=\"tab-description\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv class=\"panel entry-content active\" id=\"tab-description\"\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cspan style=\"color: #333333; font-size: 16px;\"\u003e2022 HFSA AHFTC Board Review The HFSA Virtual AHFTC Board Certification Review 2022 will be comprised of renowned heart failure experts presenting curriculum that has been tailored to the actual ABIM AHFTC examination blueprint. The educational content is rigorous, up-to-date, scientifically fair, and balanced, and meets the needs of heart failure providers who care for patients with heart failure. The live program took place August 12-14, 2022.\u003c\/span\u003e\n\u003cbr\u003e\u003ch3\u003e\u003cstrong\u003e63 MP4 +  44 PDF\u003c\/strong\u003e\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv class=\"panel entry-content active\" id=\"tab-description\"\u003e\n\u003ch3\u003e\u003cstrong\u003eContent:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch3\u003eDay 1\u003c\/h3\u003e\n\u003ch5\u003eSession 1 : Cardiac Transplantation\u003c\/h5\u003e\n\u003cul\u003e\n\u003cli\u003e-Welcome and HFSA Introduction\u003cbr\u003eAkshay Desai, MD, MPH, FHFSA\u003cbr\u003eJohn Barnes, HFSA CEO\u003c\/li\u003e\n\u003cli\u003e-Advanced Heart Failure: Defining the Phenotype and\u003cbr\u003ePatient Selection for Advanced Therapies (with LIVE\u003cbr\u003eQ\u0026amp;A)\u003cbr\u003eNancy Sweitzer, MD, PhD, FHFSA\u003c\/li\u003e\n\u003cli\u003e-Immunology: The Basics, PRA, Sensitization,\u003cbr\u003eCrossmatch( PDF)\u003cbr\u003eSean Pinney, MD\u003c\/li\u003e\n\u003cli\u003eLIVE Q\u0026amp;A:\u003cbr\u003e-Managing Immunosuppression and Drugs\u003cbr\u003e-Heart Transplant, Clinical Outcomes and Complications\u003cbr\u003eMichelle Kittleson, MD, PhD\u003c\/li\u003e\n\u003cli\u003e-Heart Transplant, Clinical Outcomes and Complications\u003cbr\u003eMichelle Kittleson, MD, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eDay 2\u003c\/h4\u003e\n\u003cbr\u003e-Welcome and Introductions (LIVE)\u003cbr\u003eAkshay Desai, MD, MPH, FHFSA\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eSESSION II: Key Issues in HF Management (Part I)\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e-Hemodynamics in HF II (with LIVE Q\u0026amp;A)\u003cbr\u003eJames C. Fang, MD, FHFSA\u003c\/li\u003e\n\u003cli\u003e-Optimal Medical Therapy for HFrEF (1)\u003cbr\u003eMark Drazner, MD, MSc, FHFSA\u003c\/li\u003e\n\u003cli\u003e-Optimal Medical Therapy for HFrEF (2)\u003cbr\u003eMark Drazner, MD, MSc, FHFSA\u003c\/li\u003e\n\u003cli\u003e-LIVE Q\u0026amp;A:\u003cbr\u003e-Optimal Medical Therapy for HFrEF\u003cbr\u003eMark Drazner, MD, MSc, FHFSA\u003c\/li\u003e\n\u003cli\u003e-HFpEF: Epidemiology, Risk Factors, Diagnosis,\u003cbr\u003eManagement – for the boards (with LIVE Q\u0026amp;A)\u003cbr\u003eSanjiv Shah, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eSESSION II: Key Issues in HF Management (Part II)\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e-Management of the Hospitalized HF Patient\u003cbr\u003eMaria Rosa Costanzo, MD\u003c\/li\u003e\n\u003cli\u003e-Pulmonary Hypertension – Therapy (with LIVE Q\u0026amp;A)\u003cbr\u003eJonathan Rich, MD, FHFSA\u003c\/li\u003e\n\u003cli\u003e-Management of Common Arrhythmias – Atrial Fib and\u003cbr\u003eFlutter\u003cbr\u003eRoderick Tung, MD\u003c\/li\u003e\n\u003cli\u003e-LIVE Q\u0026amp;A:\u003cbr\u003e-Management of Common Arrhythmias I – Atrial Fib and\u003cbr\u003eFlutter\u003cbr\u003e-Management of Common Arrhythmias II\u003cbr\u003eRoderick Tung, MD\u003c\/li\u003e\n\u003cli\u003e-Device Therapy in Heart Failure I – Sudden Death\u003cbr\u003ePrevention\u003cbr\u003eWendy Tzou, MD, FACC, FHRS\u003c\/li\u003e\n\u003cli\u003e-Device Therapy in Heart Failure II – CRT\u003cbr\u003eWendy Tzou, MD, FACC, FHRS\u003c\/li\u003e\n\u003cli\u003e-LIVE Q\u0026amp;A:\u003cbr\u003e-Device Therapy in Heart Failure I – Sudden Death\u003cbr\u003ePrevention\u003cbr\u003e-Device Therapy in Heart Failure II – CRT\u003cbr\u003eWendy Tzou, MD, FACC, FHRS\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eSESSION II: Key Issues in HF Management (Part III)\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e-Management of Comorbidities in Heart Failure – Iron\u003cbr\u003eDeficiencies\/Anemia (with LIVE Q\u0026amp;A)\u003cbr\u003eMaria Rosa Costanzo, MD\u003c\/li\u003e\n\u003cli\u003e-Cardio Renal Failure Interactions in Heart Failure\u003cbr\u003e(with LIVE Q\u0026amp;A)\u003cbr\u003eJeff Testani, MD, MTR\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eSESSION III: Specific Heart Failure Syndromes\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e-Specific Etiologies of HF I: Common Etiologies – CAD,\u003cbr\u003eETOH, Peripartum, Myocarditis (with LIVE Q\u0026amp;A)\u003cbr\u003eAkshay Desai, MD, MPH, FHFSA\u003c\/li\u003e\n\u003cli\u003e-Specific Etiologies of HF II: Inherited HF syndromes\u003cbr\u003eincluding HCM, ARVC, and LVNC (with LIVE Q\u0026amp;A)\u003cbr\u003eJane Wilcox, MD, MSc, FHFSA\u003c\/li\u003e\n\u003cli\u003e-Specific Etiologies of HF III: Infiltrative Disorders\u003cbr\u003eand Restrictive Cardiomyopathy – Amyloidosis,\u003cbr\u003eSarcoidosis, Hemochromatosis, Fabry (with LIVE Q\u0026amp;A)\u003cbr\u003eSanjiv Shah, MD\u003c\/li\u003e\n\u003cli\u003e-Q\u0026amp;A Faculty Panel – Day 2\u003c\/li\u003e\n\u003cli\u003eQ\u0026amp;A Faculty Panel\u003cbr\u003eProgram Co-Chairs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eDay 3\u003c\/h4\u003e\n\u003cbr\u003e-Welcome and Introductions (LIVE)\u003cbr\u003eAkshay Desai, MD, MPH, FHFSA\u003cbr\u003e\u003ch4\u003eSESSION IV: Shock\/MCS\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e-Cardiogenic Shock Management (with LIVE Q\u0026amp;A)\u003cbr\u003eNancy Sweitzer, MD, PhD, FHFSA\u003c\/li\u003e\n\u003cli\u003e-MCS I: Durable MCS Devices and Outcomes (with LIVE\u003cbr\u003eQ\u0026amp;A)\u003cbr\u003eJoseph Rogers, MD\u003c\/li\u003e\n\u003cli\u003e-MCS II: Temporary Support Devices and ECMO for the\u003cbr\u003eBoards\u003cbr\u003eJennifer Cowger, MD, MS\u003c\/li\u003e\n\u003cli\u003e-LIVE Q\u0026amp;A\u003c\/li\u003e\n\u003cli\u003eMCS IV: Interactive Shock and Device Management (Note:\u003cbr\u003eLive Session)\u003cbr\u003eDaniel Burkhoff, MD, PhD\u003cbr\u003eJennifer Cowger, MD, MS\u003cbr\u003eJoseph Rogers, MD\u003cbr\u003eNancy Sweitzer, MD, PhD, FHFSA\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eSESSION V: Special Topics in HF\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e-Assessment of Functional Capacity including\u003cbr\u003eCardiopulmonary Exercise Testing (with LIVE Q\u0026amp;A)\u003cbr\u003eGregory Lewis, MD\u003c\/li\u003e\n\u003cli\u003e-Healthcare Disparities in HF (with LIVE Q\u0026amp;A)\u003cbr\u003eKhadijah Breathett, MD, MS, FACC, FAHA, FHFSA\u003c\/li\u003e\n\u003cli\u003e-Issues in Chronic HF Disease Management – Biomarkers,\u003cbr\u003eRemote Monitoring, Lifestyle Interventions (with LIVE\u003cbr\u003eQ\u0026amp;A)\u003cbr\u003eAkshay Desai, MD, MPH, FHFSA\u003c\/li\u003e\n\u003cli\u003e-Management of Left Sided Valvular Heart Disease in\u003cbr\u003eHeart Failure including Functional MR, Low Gradient AS\u003cbr\u003e(with LIVE Q\u0026amp;A)\u003cbr\u003eJane Wilcox, MD, MSc, FHFSA\u003c\/li\u003e\n\u003cli\u003e-Adult Congenital Heart Disease for the HF Specialist\u003cbr\u003e(with LIVE Q\u0026amp;A)\u003cbr\u003eEric Krieger, MD\u003c\/li\u003e\n\u003cli\u003eQ\u0026amp;A Faculty Panel – Day 3\u003c\/li\u003e\n\u003cli\u003e-Q\u0026amp;A Faculty Panel\u003c\/li\u003e\n\u003cli\u003eProgram Co-Chairs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e————-\u003cbr\u003eHeart Failure Fundamentals\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e-Heart Failure Epidemiology and Risk Factors\u003cbr\u003e-Pathophysiology I: Cellular and Energetic onsideration\u003cbr\u003e-Pathophysiology II: Hemodynamic, Structural, and\u003cbr\u003eNeurohormonal Considerations\u003cbr\u003e-Diagnosis and Clinical Assessment\u003cbr\u003e-Cardio-Oncology for the Heart Failure Boards\u003cbr\u003e– Clinico-Pathologic Correlates in Heart Failure Images\u003cbr\u003efor the Heart Failure Boards\u003cbr\u003e-Statistics for the HF Board\u003cbr\u003e-Hemodynamics in Heart Failure\u003cbr\u003e-Pulmonary (arterial) hypertension:Classification and\u003cbr\u003eEvaluation\u003cbr\u003e-Comorbidities in Heart Failure: Focus on Diabetes and\u003cbr\u003eCOPD\u003cbr\u003e-RV Failure and TR Management\u003cbr\u003e-Management of Comorbidities in Heart Failure – Sleep\u003cbr\u003eDisorder\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954281549922,"sku":"MED-AMB00164","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/2022-HFSA-AHFTC-Board-Review.jpg?v=1779369846","url":"https:\/\/meducourse.com\/products\/2022-hfsa-ahftc-board-review","provider":"Meducourse","version":"1.0","type":"link"}